There are new Canadian recommendations for who should actually get Paxlovid at this point, guided by a growing body of ...
COVID vaccine booster shots were rolled out, and about 40 percent of US adults said they did not plan on getting a booster.
GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents ...
The general mood among these heavyweight investors is divided, with 44% leaning bullish and 44% bearish. Among these notable options, 5 are puts, totaling $273,893, and 4 are calls, amounting to ...
Kirkland, QC and Hamilton, ON, April 23, 2024 /CNW/ - During National Immunization Awareness Week, Pfizer Canada and McMaster ...
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved BEQVEZ™ (fidanacogene ...
A Senate Committee is investigating the “outrageously high” US price tags of the blockbuster diabetes and obesity drugs.
The most undervalued biotech stocks to buy in April are intriguing value options with mature biotech plays that boast ...
Global deaths from viral hepatitis are rising, despite progress with prevention and better tools for diagnosis and treatment, ...
Pfizer (NYSE: PFE) isn't exactly a hot stock right now. Since its massive run-up during the pandemic's height, built on hopes for its coronavirus vaccine, new sources of growth haven't led to equally ...
Request To Download Free Sample of This Strategic Report @- Antihypertensive Drugs Market is valued at approximately USD 23.2 million in 2019 and is anticipated to grow with a healthy growth rate of ...
Request To Download Free Sample of This Strategic Report @- ...